Search

everythinglearnresearchcommunity

for

Search:↓

Brain-made chemicals can control nerve cell function differently in various parts of a mouse's brain, which may help us understand neurological conditions.

Blocking a specific receptor slows down hair loss in mice.

Neurotrophins are important for hair growth and could help treat hair loss.

Increasing neurotrophin 4 in skin boosts nerve endings but not sensory neuron count.

Potassium channel openers like minoxidil boost hair growth.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

NKCC1 transporters help control neuron excitability and inhibition.

Using neurohormones to control keratin can lead to new skin disease treatments.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

The microneedle system shows promise for non-invasive brain drug delivery.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

JAK inhibitors might help treat alopecia areata.

Blocking the KATP channel may help treat migraines.

Finasteride may help improve certain brain function issues linked to dopamine.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

New compounds may help treat heart disease by activating specific potassium channels.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.